Compile Data Set for Download or QSAR

Found 525 hits with Last Name = 'thompson' and Initial = 'jb'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Nociceptin receptor (Homo sapiens (Human))	BDBM558072 (US11365191, Example 12) Show SMILES Fc1cnc(nc1)[C@H]1CC[C@H](CCNC2CCOCC2)CC1 |r,wU:10.11,wD:7.7,(-8,-1.41,;-6.67,-2.18,;-6.67,-3.72,;-5.33,-4.49,;-4,-3.72,;-4,-2.18,;-5.33,-1.41,;-2.67,-4.49,;-2.67,-6.03,;-1.33,-6.8,;,-6.03,;1.33,-6.8,;2.67,-6.03,;4,-6.8,;5.33,-6.03,;6.67,-6.8,;8,-6.03,;8,-4.49,;6.67,-3.72,;5.33,-4.49,;,-4.49,;-1.33,-3.72,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558095 (US11365191, Example 187) Show SMILES CN1CCC(CC1)NCCC1CCC(CC1)c1ccncc1C |(8,.38,;6.67,-.38,;6.67,-1.93,;5.33,-2.69,;4,-1.93,;4,-.38,;5.33,.38,;2.67,-2.69,;1.33,-1.93,;,-2.69,;-1.33,-1.93,;-2.67,-2.69,;-4,-1.93,;-4,-.38,;-2.67,.38,;-1.33,-.38,;-5.33,.38,;-5.33,1.93,;-6.67,2.69,;-8,1.93,;-8,.38,;-6.67,-.38,;-6.67,-1.93,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558074 (US11365191, Example 51) Show SMILES CNC(=O)C1(CCOCC1)NCC[C@H]1CC[C@@H](CC1)c1ncc(F)cc1C(F)(F)F |r,wU:13.13,wD:16.20,(7.62,-9.8,;7.22,-8.31,;5.73,-7.91,;4.64,-9,;5.33,-6.42,;6.67,-7.19,;8,-6.42,;8,-4.88,;6.67,-4.11,;5.33,-4.88,;4,-7.19,;2.67,-6.42,;1.33,-7.19,;,-6.42,;-1.33,-7.19,;-2.67,-6.42,;-2.67,-4.88,;-1.33,-4.11,;,-4.88,;-4,-4.11,;-5.33,-4.88,;-6.67,-4.11,;-6.67,-2.57,;-8,-1.8,;-5.33,-1.8,;-4,-2.57,;-2.67,-1.8,;-1.33,-1.03,;-4,-1.03,;-2.67,-3.34,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558075 (US11365191, Example 88) Show SMILES Cc1nccnc1[C@H]1CC[C@H](CCNC2CCOCC2)CC1 |r,wU:10.11,wD:7.7,(-3.33,-2.63,;-4.67,-3.4,;-6,-2.63,;-7.34,-3.4,;-7.34,-4.94,;-6,-5.71,;-4.67,-4.94,;-3.33,-5.71,;-3.33,-7.25,;-2,-8.02,;-.67,-7.25,;.67,-8.02,;2,-7.25,;3.33,-8.02,;4.67,-7.25,;6,-8.02,;7.34,-7.25,;7.34,-5.71,;6,-4.94,;4.67,-5.71,;-.67,-5.71,;-2,-4.94,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558076 (US11365191, Example 106) Show SMILES CC1(CCCC1)NCCC1CCC(CC1)c1cccc(F)c1Cl |(4.67,-.29,;5.44,-1.62,;6.12,-3,;7.64,-2.78,;7.9,-1.26,;6.54,-.54,;4.1,-2.39,;2.77,-1.62,;1.43,-2.39,;.1,-1.62,;-1.23,-2.39,;-2.57,-1.62,;-2.57,-.08,;-1.23,.69,;.1,-.08,;-3.9,.69,;-3.9,2.23,;-5.23,3,;-6.57,2.23,;-6.57,.69,;-7.9,-.08,;-5.23,-.08,;-5.23,-1.62,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558077 (US11365191, Example 111) Show SMILES Cc1ccncc1C1CCC(CCNC2(C)CCCC2)CC1 |(-5.9,-1.62,;-5.9,-.08,;-7.23,.69,;-7.23,2.23,;-5.9,3,;-4.57,2.23,;-4.57,.69,;-3.23,-.08,;-3.23,-1.62,;-1.9,-2.39,;-.57,-1.62,;.77,-2.39,;2.1,-1.62,;3.44,-2.39,;4.77,-1.62,;4,-.29,;5.45,-3,;6.97,-2.78,;7.23,-1.26,;5.87,-.54,;-.57,-.08,;-1.9,.69,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558078 (US11365191, Example 114) Show SMILES NC(=O)C1(CCCC1)NCCC1CCC(CC1)c1cccc(F)c1Cl |(7.06,-3.18,;5.73,-2.41,;4.96,-3.75,;5.73,-.87,;7.26,-.74,;7.61,.76,;6.29,1.55,;5.13,.55,;4.39,-1.64,;3.06,-.87,;1.73,-1.64,;.39,-.87,;-.94,-1.64,;-2.27,-.87,;-2.27,.67,;-.94,1.44,;.39,.67,;-3.61,1.44,;-3.61,2.98,;-4.94,3.75,;-6.28,2.98,;-6.28,1.44,;-7.61,.67,;-4.94,.67,;-4.94,-.87,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558079 (US11365191, Example 116) Show SMILES NC(=O)C1(CCCC1)NCCC1CCC(CC1)c1ncccc1Cl |(6.39,-3.18,;5.06,-2.41,;4.29,-3.75,;5.06,-.87,;6.59,-.74,;6.94,.76,;5.62,1.55,;4.46,.55,;3.73,-1.64,;2.39,-.87,;1.06,-1.64,;-.27,-.87,;-1.61,-1.64,;-2.94,-.87,;-2.94,.67,;-1.61,1.44,;-.27,.67,;-4.28,1.44,;-4.28,2.98,;-5.61,3.75,;-6.94,2.98,;-6.94,1.44,;-5.61,.67,;-5.61,-.87,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558080 (US11365191, Example 117) Show SMILES Cc1cccnc1C1CCC(CCNC2(CCCC2)C(N)=O)CC1 |(-5.61,-.87,;-5.61,.67,;-6.94,1.44,;-6.94,2.98,;-5.61,3.75,;-4.28,2.98,;-4.28,1.44,;-2.94,.67,;-2.94,-.87,;-1.61,-1.64,;-.27,-.87,;1.06,-1.64,;2.39,-.87,;3.73,-1.64,;5.06,-.87,;6.59,-.74,;6.94,.76,;5.62,1.55,;4.46,.55,;5.06,-2.41,;6.39,-3.18,;4.29,-3.75,;-.27,.67,;-1.61,1.44,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558081 (US11365191, Example 118) Show SMILES Cc1ccncc1C1CCC(CCNC2(CCCC2)C(N)=O)CC1 |(-5.61,-.87,;-5.61,.67,;-6.94,1.44,;-6.94,2.98,;-5.61,3.75,;-4.28,2.98,;-4.28,1.44,;-2.94,.67,;-2.94,-.87,;-1.61,-1.64,;-.27,-.87,;1.06,-1.64,;2.39,-.87,;3.73,-1.64,;5.06,-.87,;6.59,-.74,;6.94,.76,;5.62,1.55,;4.46,.55,;5.06,-2.41,;6.39,-3.18,;4.29,-3.75,;-.27,.67,;-1.61,1.44,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558082 (US11365191, Example 121) Show SMILES Cc1cnccc1C1CCC(CCNC2(C)CCCC2)CC1 |(-5.9,-1.62,;-5.9,-.08,;-7.24,.69,;-7.24,2.23,;-5.9,3,;-4.57,2.23,;-4.57,.69,;-3.23,-.08,;-3.23,-1.62,;-1.9,-2.39,;-.57,-1.62,;.77,-2.39,;2.1,-1.62,;3.43,-2.39,;4.77,-1.62,;3.68,-.53,;5.44,-3,;6.96,-2.79,;7.24,-1.28,;5.88,-.55,;-.57,-.08,;-1.9,.69,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558083 (US11365191, Example 123) Show SMILES Cc1cnccc1C1CCC(CCNC2(CCCC2)C(N)=O)CC1 |(-5.61,-.87,;-5.61,.67,;-6.94,1.44,;-6.94,2.98,;-5.61,3.75,;-4.28,2.98,;-4.28,1.44,;-2.94,.67,;-2.94,-.87,;-1.61,-1.64,;-.27,-.87,;1.06,-1.64,;2.39,-.87,;3.73,-1.64,;5.06,-.87,;6.59,-.74,;6.94,.76,;5.62,1.55,;4.46,.55,;5.06,-2.41,;6.39,-3.18,;4.29,-3.75,;-.27,.67,;-1.61,1.44,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558084 (US11365191, Example 139) Show SMILES Cc1cnccc1C1CCC(CCNC2(C)CCOCC2)CC1 |(-5.82,-1.54,;-5.82,,;-7.16,.77,;-7.16,2.31,;-5.82,3.08,;-4.49,2.31,;-4.49,.77,;-3.16,,;-3.16,-1.54,;-1.82,-2.31,;-.49,-1.54,;.85,-2.31,;2.18,-1.54,;3.51,-2.31,;4.85,-1.54,;4.85,-3.08,;6.39,-1.54,;7.16,-.21,;6.39,1.13,;4.85,1.13,;4.08,-.21,;-.49,,;-1.82,.77,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558085 (US11365191, Example 146) Show SMILES COCC1(CCOCC1)NCCC1CCC(CC1)c1ncccc1Cl |(7.34,-2.69,;6,-3.47,;4.67,-2.69,;4.67,-1.15,;6.21,-1.15,;6.98,.18,;6.21,1.51,;4.67,1.51,;3.9,.18,;3.33,-1.93,;2,-1.15,;.67,-1.93,;-.67,-1.15,;-2,-1.93,;-3.33,-1.15,;-3.33,.38,;-2,1.15,;-.67,.38,;-4.67,1.15,;-4.67,2.69,;-6,3.47,;-7.34,2.69,;-7.34,1.15,;-6,.39,;-6,-1.15,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558086 (US11365191, Example 171) Show SMILES CC(=O)N1CCC(CC1)NCCC1CCC(CC1)c1cccc(F)c1Cl |(7.34,1.15,;7.34,-.38,;8.67,-1.15,;6,-1.15,;6,-2.69,;4.67,-3.47,;3.33,-2.69,;3.33,-1.15,;4.67,-.38,;2,-3.47,;.67,-2.69,;-.67,-3.47,;-2,-2.69,;-3.33,-3.46,;-4.67,-2.69,;-4.67,-1.15,;-3.33,-.38,;-2,-1.15,;-6,-.38,;-7.34,-1.15,;-8.67,-.38,;-8.67,1.15,;-7.34,1.93,;-7.34,3.47,;-6,1.15,;-4.67,1.93,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558087 (US11365191, Example 172) Show SMILES CC(=O)N1CCC(CC1)NCCC1CCC(CC1)c1ncc(F)cc1Cl |(8,1.92,;8,.38,;9.34,-.38,;6.67,-.39,;6.67,-1.93,;5.33,-2.7,;4,-1.93,;4,-.39,;5.33,.38,;2.67,-2.7,;1.33,-1.93,;,-2.7,;-1.33,-1.93,;-2.67,-2.69,;-4,-1.93,;-4,-.39,;-2.67,.38,;-1.33,-.39,;-5.33,.38,;-5.33,1.92,;-6.67,2.7,;-8,1.92,;-9.34,2.69,;-8,.38,;-6.67,-.39,;-6.67,-1.93,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558088 (US11365191, Example 173) Show SMILES CC(=O)N1CCC(CC1)NCCC1CCC(CC1)c1ncccc1Cl |(7.34,1.92,;7.34,.38,;8.67,-.38,;6,-.39,;6,-1.93,;4.67,-2.7,;3.33,-1.93,;3.33,-.39,;4.67,.38,;2,-2.7,;.67,-1.93,;-.67,-2.7,;-2,-1.93,;-3.33,-2.69,;-4.67,-1.93,;-4.67,-.39,;-3.33,.38,;-2,-.39,;-6,.38,;-6,1.92,;-7.34,2.7,;-8.67,1.92,;-8.67,.38,;-7.34,-.39,;-7.34,-1.93,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558089 (US11365191, Example 174) Show SMILES CC(=O)N1CCC(CC1)NCCC1CCC(CC1)c1ncccc1C |(7.34,1.92,;7.34,.38,;8.67,-.38,;6,-.39,;6,-1.93,;4.67,-2.7,;3.33,-1.93,;3.33,-.39,;4.67,.38,;2,-2.7,;.67,-1.93,;-.67,-2.7,;-2,-1.93,;-3.33,-2.69,;-4.67,-1.93,;-4.67,-.39,;-3.33,.38,;-2,-.39,;-6,.38,;-6,1.92,;-7.34,2.7,;-8.67,1.92,;-8.67,.38,;-7.34,-.39,;-7.34,-1.93,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558090 (US11365191, Example 175) Show SMILES CC(=O)N1CCC(CC1)NCCC1CCC(CC1)c1cnccc1C |(7.34,1.92,;7.34,.38,;8.67,-.38,;6,-.39,;6,-1.93,;4.67,-2.7,;3.33,-1.93,;3.33,-.39,;4.67,.38,;2,-2.7,;.67,-1.93,;-.67,-2.7,;-2,-1.93,;-3.33,-2.69,;-4.67,-1.93,;-4.67,-.39,;-3.33,.38,;-2,-.39,;-6,.38,;-6,1.92,;-7.34,2.7,;-8.67,1.92,;-8.67,.38,;-7.34,-.39,;-7.34,-1.93,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558091 (US11365191, Example 178) Show SMILES CC(=O)N1CCC(CC1)NCCC1CCC(CC1)c1cc(F)ccc1Cl |(7.34,1.15,;7.34,-.39,;8.67,-1.15,;6,-1.16,;6,-2.7,;4.67,-3.47,;3.33,-2.7,;3.33,-1.16,;4.67,-.39,;2,-3.47,;.67,-2.7,;-.67,-3.47,;-2,-2.7,;-3.33,-3.46,;-4.67,-2.7,;-4.67,-1.16,;-3.33,-.39,;-2,-1.16,;-6,-.39,;-6,1.15,;-7.34,1.93,;-7.34,3.47,;-8.67,1.15,;-8.67,-.39,;-7.34,-1.16,;-7.34,-2.7,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558092 (US11365191, Example 179) Show SMILES CN1CCC(CC1)NCCC1CCC(CC1)c1cccc(F)c1Cl |(8,-.38,;6.67,-1.15,;6.67,-2.69,;5.33,-3.47,;4,-2.69,;4,-1.15,;5.33,-.38,;2.67,-3.47,;1.33,-2.69,;,-3.47,;-1.33,-2.69,;-2.67,-3.46,;-4,-2.69,;-4,-1.15,;-2.67,-.38,;-1.33,-1.15,;-5.33,-.38,;-6.67,-1.15,;-8,-.38,;-8,1.15,;-6.67,1.93,;-6.67,3.47,;-5.33,1.15,;-4,1.93,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558093 (US11365191, Example 181) Show SMILES CN1CCC(CC1)NCCC1CCC(CC1)c1ncccc1Cl |(8,.38,;6.67,-.38,;6.67,-1.93,;5.33,-2.69,;4,-1.93,;4,-.38,;5.33,.38,;2.67,-2.69,;1.33,-1.93,;,-2.69,;-1.33,-1.93,;-2.67,-2.69,;-4,-1.93,;-4,-.38,;-2.67,.38,;-1.33,-.38,;-5.33,.38,;-5.33,1.93,;-6.67,2.69,;-8,1.93,;-8,.38,;-6.67,-.38,;-6.67,-1.93,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558094 (US11365191, Example 182) Show SMILES CN1CCC(CC1)NCCC1CCC(CC1)c1ncccc1C |(8,.38,;6.67,-.38,;6.67,-1.93,;5.33,-2.69,;4,-1.93,;4,-.38,;5.33,.38,;2.67,-2.69,;1.33,-1.93,;,-2.69,;-1.33,-1.93,;-2.67,-2.69,;-4,-1.93,;-4,-.38,;-2.67,.38,;-1.33,-.38,;-5.33,.38,;-5.33,1.93,;-6.67,2.69,;-8,1.93,;-8,.38,;-6.67,-.38,;-6.67,-1.93,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM558073 (4-((2-((trans)-4-(5-fluoro-3-(trifluoromethyl)pyri...) Show SMILES CNC(=O)C1(CCOCC1)NCC[C@H]1CC[C@H](CC1)c1ncc(F)cc1C(F)(F)F |r,wD:16.20,13.13,(7.62,1.03,;7.22,2.52,;5.73,2.92,;4.64,1.83,;5.33,4.41,;6.67,3.64,;8,4.41,;8,5.95,;6.67,6.72,;5.33,5.95,;4,3.64,;2.67,4.41,;1.33,3.64,;,4.41,;,5.95,;-1.33,6.72,;-2.67,5.95,;-2.67,4.41,;-1.33,3.64,;-4,6.72,;-5.33,5.95,;-6.67,6.72,;-6.67,8.26,;-8,9.03,;-5.33,9.03,;-4,8.26,;-2.67,9.03,;-1.33,9.8,;-4,9.8,;-2.67,7.49,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Cathepsin K (Homo sapiens (Human))	BDBM50148310 (((S)-1-Formyl-pentyl)-carbamic acid (S)-1-benzyl-p...) Show SMILES CCCC[C@H](NC(=O)O[C@@H](CC)Cc1ccccc1)C=O Show InChI InChI=1S/C17H25NO3/c1-3-5-11-15(13-19)18-17(20)21-16(4-2)12-14-9-7-6-8-10-14/h6-10,13,15-16H,3-5,11-12H2,1-2H3,(H,18,20)/t15-,16-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.130	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibitory concentration against recombinant human cathepsin K determined in a fluorescence assay using 10 microM Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem Lett 14: 3425-9 (2004) Article DOI: 10.1016/j.bmcl.2004.04.084 BindingDB Entry DOI: 10.7270/Q2SF2VMD
					More data for this Ligand-Target Pair				3D Structure (docked)
Cathepsin K (Homo sapiens (Human))	BDBM50148292 (((S)-1-Formyl-pentyl)-carbamic acid 1-benzyl-cyclo...) Show SMILES CCCC[C@H](NC(=O)OC1(Cc2ccccc2)CCCC1)C=O Show InChI InChI=1S/C19H27NO3/c1-2-3-11-17(15-21)20-18(22)23-19(12-7-8-13-19)14-16-9-5-4-6-10-16/h4-6,9-10,15,17H,2-3,7-8,11-14H2,1H3,(H,20,22)/t17-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL DrugBank PC cid PC sid PDB UniChem Similars	DrugBank PDB Article PubMed	n/a	n/a	0.350	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibitory concentration against recombinant human cathepsin K determined in a fluorescence assay using 10 microM Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem Lett 14: 3425-9 (2004) Article DOI: 10.1016/j.bmcl.2004.04.084 BindingDB Entry DOI: 10.7270/Q2SF2VMD
					More data for this Ligand-Target Pair				3D Structure (crystal)
Cathepsin K (Homo sapiens (Human))	BDBM50148298 (((S)-1-Formyl-pentyl)-carbamic acid (R)-1-benzyl-2...) Show SMILES CCCC[C@H](NC(=O)O[C@H](Cc1ccccc1)C(C)C)C=O Show InChI InChI=1S/C18H27NO3/c1-4-5-11-16(13-20)19-18(21)22-17(14(2)3)12-15-9-7-6-8-10-15/h6-10,13-14,16-17H,4-5,11-12H2,1-3H3,(H,19,21)/t16-,17+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL DrugBank PC cid PC sid PDB UniChem Similars	DrugBank PDB Article PubMed	n/a	n/a	0.5	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibitory concentration against recombinant human cathepsin K determined in a fluorescence assay using 10 microM Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem Lett 14: 3425-9 (2004) Article DOI: 10.1016/j.bmcl.2004.04.084 BindingDB Entry DOI: 10.7270/Q2SF2VMD
					More data for this Ligand-Target Pair				3D Structure (crystal)
Cathepsin K (Homo sapiens (Human))	BDBM50148307 (((S)-1-Formyl-pentyl)-carbamic acid 1-isopropyl-2-...) Show SMILES CCCC[C@H](NC(=O)OC(C(C)C)C(C)C)C=O Show InChI InChI=1S/C14H27NO3/c1-6-7-8-12(9-16)15-14(17)18-13(10(2)3)11(4)5/h9-13H,6-8H2,1-5H3,(H,15,17)/t12-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.560	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibitory concentration against recombinant human cathepsin K determined in a fluorescence assay using 10 microM Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem Lett 14: 3425-9 (2004) Article DOI: 10.1016/j.bmcl.2004.04.084 BindingDB Entry DOI: 10.7270/Q2SF2VMD
					More data for this Ligand-Target Pair
Cathepsin K (Homo sapiens (Human))	BDBM50148300 (((S)-1-Formyl-pentyl)-carbamic acid 1-propyl-butyl...) Show SMILES CCCC[C@H](NC(=O)OC(CCC)CCC)C=O Show InChI InChI=1S/C14H27NO3/c1-4-7-10-12(11-16)15-14(17)18-13(8-5-2)9-6-3/h11-13H,4-10H2,1-3H3,(H,15,17)/t12-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.870	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibitory concentration against recombinant human cathepsin K determined in a fluorescence assay using 10 microM Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem Lett 14: 3425-9 (2004) Article DOI: 10.1016/j.bmcl.2004.04.084 BindingDB Entry DOI: 10.7270/Q2SF2VMD
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557916 (US11365191, Example 54) Show SMILES Fc1ccc([C@@H]2CC[C@H](CCNC3CCC(F)(F)C3)CC2)c(Cl)c1 |r,wD:5.4,8.8,(-8.55,2.69,;-7.22,1.93,;-7.22,.38,;-5.89,-.38,;-4.55,.38,;-3.22,-.38,;-1.89,.38,;-.55,-.38,;-.55,-1.93,;.78,-2.69,;2.12,-1.93,;3.45,-2.69,;4.78,-1.93,;4.94,-.39,;6.45,-.07,;7.22,-1.41,;8.55,-2.18,;8.55,-.64,;6.19,-2.55,;-1.89,-2.69,;-3.22,-1.93,;-4.55,1.93,;-3.22,2.69,;-5.89,2.69,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557912 (US11365191, Example 25) Show SMILES OC1COCCC1NCC[C@H]1CC[C@H](CC1)c1ccc(F)cc1Cl |r,wU:13.17,10.10,(6.67,-3.47,;6.67,-1.93,;8,-1.16,;8,.38,;6.67,1.15,;5.33,.38,;5.33,-1.16,;4,-1.93,;2.67,-1.16,;1.33,-1.93,;,-1.16,;-1.33,-1.93,;-2.67,-1.16,;-2.67,.38,;-1.33,1.15,;,.38,;-4,1.15,;-5.33,.38,;-6.67,1.15,;-6.67,2.69,;-8,3.46,;-5.33,3.47,;-4,2.69,;-2.67,3.46,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557913 (US11365191, Example 27) Show SMILES OC1CCCC1NCC[C@H]1CC[C@H](CC1)c1ccc(F)cc1Cl |r,wU:12.16,9.9,(7.26,-3.37,;6.86,-1.88,;7.89,-.73,;7.12,.6,;5.61,.28,;5.45,-1.25,;4.12,-2.02,;2.78,-1.25,;1.45,-2.02,;.11,-1.25,;-1.22,-2.02,;-2.55,-1.25,;-2.55,.29,;-1.22,1.06,;.11,.29,;-3.89,1.06,;-5.22,.29,;-6.55,1.06,;-6.55,2.6,;-7.89,3.37,;-5.22,3.37,;-3.89,2.6,;-2.55,3.37,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Integrase (Human immunodeficiency virus 1)	BDBM50484379 (CHEMBL1917873) Show SMILES CC(C)n1c2cccnc2c(O)c(C(=O)NCc2ccc(F)cc2)c1=O Show InChI InChI=1S/C19H18FN3O3/c1-11(2)23-14-4-3-9-21-16(14)17(24)15(19(23)26)18(25)22-10-12-5-7-13(20)8-6-12/h3-9,11,24H,10H2,1-2H3,(H,22,25)	PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Research & Development Curated by ChEMBL					Assay Description Inhibition of HIV1 integrase strand transfer by biochemical assay				Bioorg Med Chem Lett 21: 6461-4 (2011) Article DOI: 10.1016/j.bmcl.2011.08.082 BindingDB Entry DOI: 10.7270/Q22Z18CH
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557915 (US11365191, Example 53) Show SMILES F[C@@H]1CC[C@@H](C1)NCCC1CCC(CC1)c1ccc(F)cc1Cl |r,wU:4.6,1.0,(8.63,-1.81,;7.14,-1.41,;6.37,-.07,;4.87,-.39,;4.71,-1.93,;6.11,-2.55,;3.37,-2.69,;2.04,-1.93,;.7,-2.69,;-.63,-1.93,;-1.96,-2.69,;-3.3,-1.93,;-3.3,-.38,;-1.96,.38,;-.63,-.38,;-4.63,.38,;-5.96,-.38,;-7.3,.38,;-7.3,1.93,;-8.63,2.69,;-5.96,2.69,;-4.63,1.93,;-3.3,2.69,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557911 (N-(2-((trans)-4-(2-chloro-6-fluorophenyl)cyclohexy...) Show SMILES Fc1cccc(Cl)c1[C@@H]1CC[C@H](CCNC2CCOCC2)CC1 |r,wD:8.8,11.12,(-6,2.3,;-6,3.84,;-7.34,4.61,;-7.34,6.15,;-6,6.92,;-4.67,6.15,;-3.33,6.92,;-4.67,4.61,;-3.33,3.84,;-2,4.61,;-.67,3.84,;-.67,2.3,;.67,1.53,;2,2.3,;3.33,1.53,;4.67,2.3,;6,1.53,;7.34,2.3,;7.34,3.84,;6,4.61,;4.67,3.84,;-2,1.53,;-3.33,2.3,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557910 (N-(2-((trans)-4-(4-fluoro-2-methylphenyl)cyclohexy...) Show SMILES Cc1cc(F)ccc1[C@@H]1CC[C@H](CCNC2CCOCC2)CC1 |r,wD:8.8,11.12,(-2.67,6.92,;-4,6.15,;-5.33,6.92,;-6.67,6.15,;-8,6.92,;-6.67,4.61,;-5.33,3.84,;-4,4.61,;-2.67,3.84,;-1.33,4.61,;,3.84,;,2.3,;1.33,1.53,;2.67,2.3,;4,1.53,;5.33,2.3,;6.67,1.53,;8,2.3,;8,3.84,;6.67,4.61,;5.33,3.84,;-1.33,1.53,;-2.67,2.3,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557893 (US11365191, Example 3) Show SMILES Fc1ccc(C2CCC(CCNC3CCOCC3)CC2)c(Cl)c1 |(-8,2.69,;-6.67,1.92,;-6.67,.38,;-5.33,-.39,;-4,.38,;-2.67,-.39,;-2.67,-1.93,;-1.33,-2.69,;,-1.93,;1.33,-2.7,;2.67,-1.93,;4,-2.7,;5.33,-1.93,;6.67,-2.7,;8,-1.93,;8,-.39,;6.67,.38,;5.33,-.39,;,-.39,;-1.33,.38,;-4,1.92,;-2.67,2.7,;-5.33,2.69,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557917 (US11365191, Example 55) Show SMILES FC1COCCC1NCC[C@H]1CC[C@H](CC1)c1ccc(F)cc1Cl |r,wD:13.17,10.10,(6.67,-3.47,;6.67,-1.93,;8,-1.15,;8,.38,;6.67,1.16,;5.33,.38,;5.33,-1.15,;4,-1.93,;2.67,-1.15,;1.33,-1.93,;,-1.15,;,.38,;-1.33,1.15,;-2.67,.38,;-2.67,-1.15,;-1.33,-1.92,;-4,1.15,;-5.33,.38,;-6.67,1.15,;-6.67,2.69,;-8,3.47,;-5.33,3.47,;-4,2.69,;-2.67,3.47,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557926 (US11365191, Example 161) Show SMILES Fc1ccc([C@@H]2CC[C@H](CCN[C@@H]3CCNC(=O)C3)CC2)c(Cl)c1 |r,wD:5.4,8.8,12.11,(-8.67,2.69,;-7.34,1.92,;-7.34,.38,;-6,-.38,;-4.67,.38,;-3.33,-.39,;-2,.38,;-.67,-.39,;-.67,-1.93,;.67,-2.7,;2,-1.93,;3.33,-2.7,;4.67,-1.93,;4.67,-.39,;6,.39,;7.34,-.39,;7.34,-1.93,;8.67,-2.69,;6,-2.7,;-2,-2.7,;-3.33,-1.93,;-4.67,1.92,;-3.33,2.7,;-6,2.69,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557925 (US11365191, Example 158) Show SMILES Fc1ccc([C@@H]2CC[C@H](CCNC3CCNC(=O)C3)CC2)c(Cl)c1 |r,wD:5.4,8.8,(-8.67,2.69,;-7.34,1.92,;-7.34,.38,;-6,-.38,;-4.67,.38,;-3.33,-.39,;-2,.38,;-.67,-.39,;-.67,-1.93,;.67,-2.7,;2,-1.93,;3.33,-2.7,;4.67,-1.93,;4.67,-.39,;6,.39,;7.34,-.39,;7.34,-1.93,;8.67,-2.69,;6,-2.7,;-2,-2.7,;-3.33,-1.93,;-4.67,1.92,;-3.33,2.7,;-6,2.69,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557924 (US11365191, Example 93) Show SMILES Fc1ccc([C@@H]2CC[C@H](CCN[C@H]3CC[C@H](CC3)C#N)CC2)c(c1)C(F)(F)F |r,wU:5.4,8.8,12.11,15.18,(-9.34,2.03,;-8,1.26,;-8,-.28,;-6.67,-1.05,;-5.33,-.28,;-4,-1.05,;-4,-2.59,;-2.67,-3.36,;-1.33,-2.59,;,-3.36,;1.33,-2.59,;2.67,-3.36,;4,-2.59,;4,-1.05,;5.33,-.28,;6.67,-1.05,;6.67,-2.59,;5.33,-3.36,;8,-.28,;9.34,.49,;-1.33,-1.05,;-2.67,-.28,;-5.33,1.26,;-6.67,2.03,;-4,2.03,;-2.67,2.8,;-4.77,3.36,;-3.23,.69,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557923 (N-(2-((trans)-4-(3-chloro-5-fluoropyridin-2-yl)cyc...) Show SMILES Fc1cnc([C@@H]2CC[C@H](CCNC3CCOCC3)CC2)c(Cl)c1 |r,wD:5.4,8.8,(-8,8.11,;-6.67,7.34,;-6.67,5.8,;-5.33,5.03,;-4,5.8,;-2.67,5.03,;-1.33,5.8,;,5.03,;,3.49,;1.33,2.72,;2.67,3.49,;4,2.72,;5.33,3.49,;6.67,2.72,;8,3.49,;8,5.03,;6.67,5.8,;5.33,5.03,;-1.33,2.72,;-2.67,3.49,;-4,7.34,;-2.67,8.11,;-5.33,8.11,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557922 (US11365191, Example 76) Show SMILES CNC(=O)C1(CCOCC1)NCC[C@H]1CC[C@H](CC1)c1ccc(F)cc1Cl |r,wD:16.20,13.13,(8,-2.54,;6.67,-3.31,;5.33,-2.54,;4.25,-3.62,;5.33,-1,;6.67,-1.77,;8,-1,;8,.54,;6.67,1.31,;5.33,.54,;4,-1.77,;2.67,-1,;1.33,-1.77,;,-1,;,.54,;-1.33,1.31,;-2.67,.54,;-2.67,-1,;-1.33,-1.77,;-4,1.31,;-5.33,.54,;-6.67,1.31,;-6.67,2.85,;-8,3.62,;-5.33,3.62,;-4,2.85,;-2.67,3.62,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557921 (US11365191, Example 64) Show SMILES Fc1ccc([C@@H]2CC[C@H](CCNC3CCCC3)CC2)c(Cl)c1 |r,wD:5.4,8.8,(-7.89,2.69,;-6.55,1.93,;-5.22,2.69,;-3.89,1.93,;-3.89,.38,;-2.55,-.38,;-1.22,.38,;.11,-.38,;.11,-1.93,;1.45,-2.69,;2.78,-1.93,;4.12,-2.69,;5.45,-1.93,;6.86,-2.55,;7.89,-1.41,;7.12,-.07,;5.61,-.39,;-1.22,-2.69,;-2.55,-1.93,;-5.22,-.38,;-5.22,-1.93,;-6.55,.38,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557920 (US11365191, Example 61) Show SMILES Fc1ccc([C@@H]2CC[C@H](CCNC3CCOCC3)CC2)c(Cl)c1 |r,wD:5.4,8.8,(-8,2.69,;-6.67,1.93,;-6.67,.38,;-5.33,-.38,;-4,.38,;-2.67,-.38,;-1.33,.38,;,-.38,;,-1.93,;1.33,-2.69,;2.67,-1.93,;4,-2.69,;5.33,-1.93,;6.67,-2.69,;8,-1.93,;8,-.38,;6.67,.39,;5.33,-.38,;-1.33,-2.69,;-2.67,-1.93,;-4,1.93,;-2.67,2.69,;-5.33,2.69,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557919 (US11365191, Example 57) Show SMILES FC1COCCC1NCC[C@H]1CC[C@@H](CC1)c1ccc(F)cc1Cl |r,wU:10.10,wD:13.17,(6.67,-8.68,;6.67,-7.14,;8,-6.37,;8,-4.83,;6.67,-4.06,;5.33,-4.83,;5.33,-6.37,;4,-7.14,;2.67,-6.37,;1.33,-7.14,;,-6.37,;-1.33,-7.14,;-2.67,-6.37,;-2.67,-4.83,;-1.33,-4.06,;,-4.83,;-4,-4.06,;-5.33,-4.83,;-6.67,-4.06,;-6.67,-2.52,;-8,-1.75,;-5.33,-1.75,;-4,-2.52,;-2.67,-1.75,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Nociceptin receptor (Homo sapiens (Human))	BDBM557918 (N-(2-((cis)-4-(2-chloro-4-fluorophenyl)cyclohexyl)...) Show SMILES FC1COCCC1NCC[C@H]1CC[C@H](CC1)c1ccc(F)cc1Cl |r,wD:13.17,10.10,(6.67,1.75,;6.67,3.29,;8,4.06,;8,5.6,;6.67,6.37,;5.33,5.6,;5.33,4.06,;4,3.29,;2.67,4.06,;1.33,3.29,;,4.06,;,5.6,;-1.33,6.37,;-2.67,5.6,;-2.67,4.06,;-1.33,3.29,;-4,6.37,;-5.33,5.6,;-6.67,6.37,;-6.67,7.91,;-8,8.68,;-5.33,8.68,;-4,7.91,;-2.67,8.68,)| Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Formula (I) compounds were tested for antagonism of the nociceptin receptor (NOP) in a cell-based cAMP assay, using the LANCE cAMP Detection Kit, Per...				Citation and Details BindingDB Entry DOI: 10.7270/Q2TF01J4
					More data for this Ligand-Target Pair
Cathepsin K (Homo sapiens (Human))	BDBM50148314 (((S)-1-Formyl-pentyl)-carbamic acid 1-isobutyl-3-m...) Show SMILES CCCC[C@H](NC(=O)OC(CC(C)C)CC(C)C)C=O Show InChI InChI=1S/C16H31NO3/c1-6-7-8-14(11-18)17-16(19)20-15(9-12(2)3)10-13(4)5/h11-15H,6-10H2,1-5H3,(H,17,19)/t14-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibitory concentration against recombinant human cathepsin K determined in a fluorescence assay using 10 microM Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem Lett 14: 3425-9 (2004) Article DOI: 10.1016/j.bmcl.2004.04.084 BindingDB Entry DOI: 10.7270/Q2SF2VMD
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1A (Mus musculus (Mouse))	BDBM50054718 (3-Amino-thiophene-2-carboxylic acid [4-(4-benzo[d]...) Show SMILES Nc1ccsc1C(=O)NCCCCN1CCN(CC1)c1nsc2ccccc12 Show InChI InChI=1S/C20H25N5OS2/c21-16-7-14-27-18(16)20(26)22-8-3-4-9-24-10-12-25(13-11-24)19-15-5-1-2-6-17(15)28-23-19/h1-2,5-7,14H,3-4,8-13,21H2,(H,22,26)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Glaxo Wellcome Inc. Curated by ChEMBL					Assay Description Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.				J Med Chem 39: 4692-703 (1997) Article DOI: 10.1021/jm9603375 BindingDB Entry DOI: 10.7270/Q2VT1R6T
					More data for this Ligand-Target Pair
Cathepsin K (Homo sapiens (Human))	BDBM50148297 (((S)-1-Formyl-pentyl)-carbamic acid (S)-1-benzyl-b...) Show SMILES CCCC[C@H](NC(=O)O[C@@H](CCC)Cc1ccccc1)C=O Show InChI InChI=1S/C18H27NO3/c1-3-5-12-16(14-20)19-18(21)22-17(9-4-2)13-15-10-7-6-8-11-15/h6-8,10-11,14,16-17H,3-5,9,12-13H2,1-2H3,(H,19,21)/t16-,17-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.5	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibitory concentration against recombinant human cathepsin K determined in a fluorescence assay using 10 microM Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem Lett 14: 3425-9 (2004) Article DOI: 10.1016/j.bmcl.2004.04.084 BindingDB Entry DOI: 10.7270/Q2SF2VMD
					More data for this Ligand-Target Pair				3D Structure (docked)

Displayed 1 to 50 (of 525 total )  |  Next  |  Last  >>

Jump to: